Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity

被引:17
作者
Hiyama, E
Hiyama, K
Nishiyama, M
Reynolds, CP
Shay, JW
Yokoyama, T
机构
[1] Childrens Hosp Los Angeles, Grad Sch Biomed Sci, Dept Gen Med, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Dept Translat Canc Res, Res Inst Radiat Biol & Med, Div Hematol Oncol, Los Angeles, CA 90027 USA
[3] Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX USA
关键词
neuroblastoma; telomerase; gene expression; microarray; prognosis;
D O I
10.1016/j.jpedsurg.2003.08.042
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose: Neuroblastoma shows remarkable heterogeneity, resulting in favorable or unfavorable outcomes. The authors previously reported that high levels of telomerase activity correlated with unfavorable tumors, and telomere shortening without telomerase activity correlated with tumor regression. To identify the genes responsible for the biological characteristics of neuroblastoma, the authors applied microarray techniques. Methods: Mixtures of total RNAs extracted from 10 neuroblastoma tissues with high and 10 with low telomerase activity were labeled with Cy3 or Cy5 by reverse transcriptase reaction, respectively, and hybridized with our original microarrays prepared with a cDNA library of human fetal brain. Results: Expression of 63 genes including MYCN, hTERT, HSPCA, and cell cycle-related proteins was found to be increased in neuroblastomas with high telomerase activity, whereas another 46 genes, including neural differentiating genes, were detected as highly expressed in tumors with low telomerase activity. Conclusions: The expression profiling data indicated clusters of upregulated and downregulated genes tumors with high or low telomerase activity. The genes involved in differentiation/growth arrest of tumor cells were closely related to low telomerase activity in neuroblastoma. The genes overexpressed in tumors with high telomerase activity, including cell-cycle-related genes and transcriptional factors, would be candidates for novel prognosis-predicting factors as well as new therapeutic targets in aggressive neuroblastomas.
引用
收藏
页码:1730 / 1734
页数:5
相关论文
共 16 条
  • [1] Neuroblastoma: Biological insights into a clinical enigma
    Brodeur, GM
    [J]. NATURE REVIEWS CANCER, 2003, 3 (03) : 203 - 216
  • [2] Cheung IY, 2001, MED PEDIATR ONCOL, V36, P210, DOI 10.1002/1096-911X(20010101)36:1<210::AID-MPO1051>3.0.CO
  • [3] 2-F
  • [4] Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
    Greenberg, RA
    O'Hagan, RC
    Deng, HY
    Xiao, QR
    Hann, SR
    Adams, RR
    Lichtsteiner, S
    Chin, L
    Morin, GB
    DePinho, RA
    [J]. ONCOGENE, 1999, 18 (05) : 1219 - 1226
  • [5] Clinical utility of telomerase in cancer
    Eiso Hiyama
    Keiko Hiyama
    [J]. Oncogene, 2002, 21 (4) : 643 - 649
  • [6] Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
    Hiyama, E
    Hiyama, K
    Ohtsu, K
    Yamaoka, H
    Ichikawa, T
    Shay, JW
    Yokoyama, T
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) : 1932 - 1936
  • [7] Hiyama E, 2002, RRD CANCER, V4, P675
  • [8] CORRELATING TELOMERASE ACTIVITY LEVELS WITH HUMAN NEUROBLASTOMA OUTCOMES
    HIYAMA, E
    HIYAMA, K
    YOKOYAMA, T
    MATSUURA, Y
    PIATYSZEK, MA
    SHAY, JW
    [J]. NATURE MEDICINE, 1995, 1 (03) : 249 - 255
  • [9] SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER
    KIM, NW
    PIATYSZEK, MA
    PROWSE, KR
    HARLEY, CB
    WEST, MD
    HO, PLC
    COVIELLO, GM
    WRIGHT, WE
    WEINRICH, SL
    SHAY, JW
    [J]. SCIENCE, 1994, 266 (5193) : 2011 - 2015
  • [10] International Neuroblastoma Staging System stage 1 neuroblastoma: A prospective study and literature review
    Kushner, BH
    Cheung, NKV
    LaQuaglia, MP
    Ambros, PF
    Ambros, IM
    Bonilla, MA
    Ladanyi, M
    Gerald, WL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) : 2174 - 2180